OTC disease, formally called ornithine transcarbamylase deficiency (OTCD), is a genetic condition where the body cannot properly remove ammonia from the blood. It is the most common urea cycle disorder, affecting roughly 1 in 62,000 to 1 in 70,000 newborns depending on the population studied. Without effective ammonia removal, the substance builds up to toxic levels and can damage the brain, making early recognition critical.
How the Urea Cycle Breaks Down
Your liver normally converts ammonia, a toxic byproduct of protein digestion, into urea, which leaves the body through urine. This conversion happens through a series of chemical steps called the urea cycle. One essential step requires an enzyme called ornithine transcarbamylase, which combines two molecules to produce citrulline and ultimately urea.
When this enzyme is missing or not working well, the cycle stalls. Ammonia accumulates in the bloodstream, a condition called hyperammonemia. At the same time, citrulline and arginine levels drop because the body can’t produce them normally. Glutamine, another amino acid, rises because the body tries to use it as an alternative ammonia sink. These shifts in blood chemistry are what doctors look for when diagnosing OTC disease.
Why It Affects Males and Females Differently
OTC deficiency is X-linked, meaning the gene responsible sits on the X chromosome. Males have only one X chromosome, so a single faulty copy of the gene is enough to cause disease. Females have two X chromosomes, and whether they develop symptoms depends on a process called X-inactivation: in each cell, one X chromosome is randomly switched off. If the healthy copy happens to be silenced in a large proportion of liver cells, a female carrier can experience symptoms just as severe as a male. If the healthy copy stays active in most cells, she may have no symptoms at all.
This means the condition ranges widely in females, from completely asymptomatic to recurrent episodes of dangerously high ammonia with neurological damage. Males who inherit the severe form almost always become symptomatic.
Neonatal-Onset Symptoms
The severe form typically appears in boys within the first week of life, most often on day two or three. These newborns seem healthy at birth but quickly develop poor feeding, weak muscle tone, and increasing drowsiness. Without treatment, the drowsiness can progress to unresponsiveness and coma. Other early signs include abnormal breathing patterns and low body temperature.
Because these symptoms overlap with infections and other newborn emergencies, OTC deficiency is easy to miss unless ammonia levels are checked. A delay in diagnosis of even hours matters, because prolonged high ammonia causes irreversible brain injury.
Late-Onset Symptoms
Not everyone with OTC deficiency gets sick as a newborn. People with partial enzyme activity, both males and females, can go undiagnosed for years or even decades. Symptoms in this group tend to be vague: recurring headaches, nausea, vomiting, confusion, or an unusual aversion to protein-rich foods. Many people unconsciously avoid meat and other high-protein foods throughout their lives without knowing why.
Episodes of high ammonia can be triggered by illness, surgery, fasting, or a sudden increase in protein intake. One published case described an adult woman who went undiagnosed her entire life despite lifelong protein aversion, only receiving a diagnosis after developing chronic vomiting, abdominal pain, and intermittent confusion. Because the symptoms mimic so many other conditions, late-onset OTC deficiency is frequently misdiagnosed as a psychiatric or gastrointestinal problem.
How OTC Disease Is Diagnosed
The first clue is usually an elevated blood ammonia level that can’t be explained by liver failure or another obvious cause. From there, a specific pattern in blood amino acids points toward OTC deficiency: low citrulline, low arginine, elevated glutamine, and elevated alanine. Ornithine levels typically remain normal, which helps distinguish it from other urea cycle disorders.
A urine test for orotic acid is the key differentiator. Orotic acid is elevated in OTC deficiency because the unused building blocks in the stalled urea cycle get shunted into a different pathway. Genetic testing of the OTC gene on the X chromosome confirms the diagnosis and can identify carriers in the family.
Daily Management Through Diet
Because ammonia comes from protein breakdown, the cornerstone of managing OTC disease is carefully controlled protein intake. The goal is to provide enough protein for growth and health while keeping ammonia in a safe range. Recommended daily protein varies by age: infants need about 1.2 to 2.2 grams per kilogram of body weight, while adults typically stay between 0.5 and 1.0 grams per kilogram.
About 30% to 50% of that protein often comes from specially formulated medical foods containing only essential amino acids. These give the body what it needs for tissue repair and growth without the excess nitrogen that drives ammonia production. People with milder forms who maintain normal ammonia and glutamine levels on a standard diet may not need these supplements at all, but they still require regular blood monitoring.
Medications that help the body eliminate nitrogen through alternative chemical pathways are another mainstay. These drugs essentially create a “back door” for nitrogen disposal, bypassing the broken urea cycle. Most people with OTC deficiency take these daily in addition to following their dietary plan.
What Happens During a Crisis
A hyperammonemic crisis is a medical emergency. It can be triggered by anything that increases protein breakdown in the body: an infection with fever, vomiting that prevents someone from eating (which pushes the body to break down its own muscle for energy), surgery, or even emotional stress. Ammonia levels can spike rapidly.
In the hospital, the immediate priorities are stopping all protein intake for 24 to 48 hours, providing high-calorie intravenous fluids to prevent the body from breaking down its own tissue, and starting intravenous nitrogen-scavenging medications. If ammonia levels remain dangerously high despite these measures, dialysis may be needed to physically filter ammonia from the blood. The threshold for starting dialysis is generally when ammonia climbs above 300 to 500 micromoles per liter without responding to medications within a few hours.
Liver Transplant as a Cure
Liver transplantation is the only treatment that fully corrects the metabolic defect in OTC deficiency, because the urea cycle operates primarily in the liver. In a retrospective study of 20 patients who received transplants, the overall survival rate was 95%. After transplant, all patients were able to stop their dietary restrictions and nitrogen-scavenging medications and remained metabolically stable.
Transplant does not reverse brain damage that occurred before the procedure. Patients who had neurodevelopmental problems before surgery continued to have difficulties afterward. Among five patients with normal development before transplant, four maintained their abilities, while one developed behavioral issues. This underscores why early diagnosis and aggressive ammonia control matter so much: the goal is to prevent neurological harm in the first place, because transplant cannot undo it.
The decision to pursue transplant involves weighing surgical risks against the ongoing risk of unpredictable metabolic crises. For patients with severe disease and frequent hospitalizations, transplant often offers a better long-term outlook. For those with milder forms well controlled by diet and medication, it may not be necessary.
Long-Term Outlook
Outcomes for people with OTC deficiency depend heavily on how early the condition is caught and how well ammonia levels are controlled over time. Males with severe neonatal-onset disease face the highest risk of brain injury, particularly if diagnosis is delayed. With prompt treatment and careful lifelong management, many people with partial deficiency lead relatively normal lives, though they must remain vigilant about triggers that could cause an ammonia spike.
Every episode of significantly elevated ammonia carries a risk of cumulative neurological damage, so the practical reality of living with OTC disease involves consistent dietary management, regular blood work, and having an emergency plan in place for illness or other stressors. Families often work closely with metabolic specialists to adjust protein intake as children grow and their nutritional needs change.